20/20 BioLabs
NASDAQ: AIDXMaryland, US · 2 known investors
20/20 BioLabs develops AI-powered blood tests for early detection of multiple cancers and chronic diseases, using protein tumor markers and machine learning. The company offers affordable, at-home collection tests starting under $200, targeting individuals and healthcare providers seeking early disease detection.
Founders & leadership
MC
Mr. CohenFounder, Chief Executive Officer, President
DL
Dr. LebowitzChief Scientific Officer
DZ
Dr. Zhou
Investors · 2
Competitors · 6
by search overlapSimply Wall St6 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
TradingView5 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Wefunder5 shared keywordsA platform that allows individuals to invest in private startups with minimum investments of $100, leveraging regulatory changes to democratize access to early-stage company equity.
Start Engine5 shared keywordsStartEngine is a crowdfunding platform that enables both accredited and non-accredited investors to invest in early-stage startups and collectibles through Regulation A+ and Regulation Crowdfunding offerings. The platform also provides a secondary trading marketplace for eligible securities.
KingsCrowd4 shared keywords
trefis4 shared keywordsTrefis operates thinkHub, a data-driven investment analytics platform that uses what it calls "Understandable-AI" — an auditable, non-black-box decision system — to build and run equity portfolios (such as its High-Quality, Bayesian, and Reinforced Value strategies) aimed at outperforming the S&P 500. It serves investors and money managers, offering peer comparisons, valuation, and macro-event analyses, with practical investing carried out via an affiliated firm.
Companies competing with 20/20 BioLabs for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does 20/20 BioLabs do?
- 20/20 BioLabs develops AI-powered blood tests for early detection of multiple cancers and chronic diseases, using protein tumor markers and machine learning. The company offers affordable, at-home collection tests starting under $200, targeting individuals and healthcare providers seeking early disease detection.
- Who founded 20/20 BioLabs?
- 20/20 BioLabs was founded by Mr. Cohen.
- Who are 20/20 BioLabs's investors?
- 20/20 BioLabs's investors include Dellin Investments, DigitalDx Ventures.
- Where is 20/20 BioLabs headquartered?
- 20/20 BioLabs is headquartered in Maryland, US.